Lawrence Rozendaal

Relation of human papilloma virus status to cervical lesions and consequences for cervical-cancer screening: a prospective study

Marielle Nobbenhuis, Jan M.M. Walboomers, Theo J.M. Helmerhorst et al. · The Lancet · 1999 · 702 citations

Epidemiology, Cervical Cancer Management, Cervical Cancer +15

Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial

NWJ Bulkmans, Johannes Berkhof, Lawrence Rozendaal et al. · The Lancet · 2007 · 643 citations

Cervical Cancer Screening, Oncology, Cervical Cancer +15

Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial

Dorien Rijkaart, Johannes Berkhof, Lawrence Rozendaal et al. · The Lancet Oncology · 2011 · 503 citations

Cervical Cancer Screening, Cervical Cancer, Cancer Detection +13

The presence of persistent high‐risk hpv genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months

Ans J. Remmink, Jan M.M. Walboomers, Theo J.M. Helmerhorst et al. · International Journal of Cancer · 1995 · 373 citations

HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study

Murat Gök, D.A.M. Heideman, Folkert J. van Kemenade et al. · BMJ · 2010 · 304 citations · Full text